Skip to main content

CITADEL ADVISORS LLC

Position in VERU — Veru Inc.

CIK 1423053 MIAMI, FL

Position in VERU

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$98,305
-$142,576 QoQ
Shares Held
44,482
-60.5% QoQ
Ownership
0.277%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VERU Over Time

Shares Held

Position Value (USD)

Derivatives in VERU

reported options exposure · as of Mar 31, 2026
CallValue
$26,078
CallShares
11,800
PutValue
$56,576
PutShares
25,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $5,784,241,435 across 374 Biotechnology names. VERU ranks #331 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in VERU

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $56,576 25,600
2026-03-31 $98,305 44,482
2026-03-31 $26,078 11,800
2025-12-31 $240,881 112,562
2025-12-31 $44,298 20,700
2025-09-30 $166,242 43,748
2025-09-30 $94,544 24,880
2025-09-30 $45,334 11,930